Paul Tudor Jones’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,100
Closed -$286K 3951
2025
Q4
$286K Sell
3,100
-4,000
-56% -$383K ﹤0.01% 3084
2025
Q3
$527K Buy
7,100
+5,400
+318% +$547K ﹤0.01% 2667
2025
Q2
$221K Sell
1,700
-1,700
-50% -$247K ﹤0.01% 3043
2025
Q1
$542K Buy
3,400
+800
+31% +$145K ﹤0.01% 2236
2024
Q4
$482K Buy
+2,600
New +$505K ﹤0.01% 2269
2024
Q1
Sell
-2,800
Closed -$570K 2473
2023
Q4
$570K Hold
2,800
﹤0.01% 1731
2023
Q3
$556K Buy
2,800
+2,000
+250% +$504K 0.01% 1624
2023
Q2
$260K Buy
+800
New +$229K ﹤0.01% 2082
2023
Q1
Sell
-2,100
Closed -$528K 2673
2022
Q4
$528K Buy
2,100
+400
+24% +$85.3K 0.01% 1549
2022
Q3
$301K Buy
+1,700
New +$342K 0.01% 1791

Other funds holding INSP

Paul Tudor Jones's INSP Position: Q2 2026 in Review

Paul Tudor Jones increased its Inspire Medical Systems (INSP) stake by 1.1% in Q2 2026, buying an estimated $89K and bringing the position to 169,095 shares worth $7.54M. The position accounts for 0.01% of the portfolio, ranked #1005.

Paul Tudor Jones first reported a position in INSP in Q4 2018 and has held it in 19 quarters since. The position peaked at $14.6M in Q4 2023. 274 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Paul Tudor Jones held 169,095 shares of Inspire Medical Systems worth $7.54M as of Q2 2026.
  • Paul Tudor Jones bought 1,877 Inspire Medical Systems shares in Q2 2026, an estimated $89K.
  • Inspire Medical Systems made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1005 holding.
  • Paul Tudor Jones first reported a position in Inspire Medical Systems in Q4 2018 and has held it in 19 quarters since.
  • Paul Tudor Jones's Inspire Medical Systems position peaked at $14.6M in Q4 2023.
  • 274 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.